• Perphenazine: Receptor and Host-Cell Workflows

  2026-08-20

  Perphenazine supports integrated dopamine receptor, mitochondrial stress, opioid tolerance, and macrophage host-defense studies. This workflow-oriented guide shows how to build controlled assays, separate receptor-mediated effects from phenothiazine-associated cytotoxicity, and translate the reference study into practical experiments.

• Pexmetinib (ARRY-614) for Cytokine Assays

  2026-08-19

  Pexmetinib (ARRY-614) combines p38 MAPK and Tie2 pathway modulation for integrated cytokine, phosphorylation, and translational inflammation workflows. This guide shows how to prepare, dose, validate, and troubleshoot the compound in stromal-cell, whole-blood, and pathway-focused assays.

• VE-822 ATR Inhibitor: Workflow and Optimization

  2026-08-19

  VE-822 is a potent, selective ATR inhibitor for dissecting replication-stress signaling and testing radiosensitization strategies. This practical guide connects dose-finding, 2D/3D assay design, PDAC chemoradiotherapy workflows, and nuclear cGAS–L1 genome-integrity research.

• Dabigatran etexilate Research Workflows

  2026-08-18

  Dabigatran etexilate gives researchers a precise way to connect thrombin activity with plasma clotting, platelet aggregation, and translational anticoagulation endpoints. This workflow-focused guide covers solvent handling, assay design, oral-prodrug considerations, and troubleshooting for atrial fibrillation and coagulation studies.

• CAY10499 and the Lipid Logic of TAM Biology

  2026-08-18

  Extracellular vesicle-transferred ACLY links tumor lipid metabolism to immunosuppressive macrophage differentiation in hepatocellular carcinoma. This article positions CAY10499 as a mechanistic research tool for testing whether HSL, MGL, fatty-acid mobilization, and endocannabinoid turnover influence that EV-to-TAM axis.

• L1023 Anti-Cancer Compound Library for STING-Aware Screens

  2026-08-17

  The L1023 Anti-Cancer Compound Library turns pathway hypotheses into practical, plate-ready cancer research workflows spanning phenotypic screening, kinase profiling, and mechanism-aware validation. Its broad chemical coverage can be paired with STING-focused readouts inspired by recent structural biology, helping researchers distinguish true pathway modulation from nonspecific cytotoxicity.

• ARCA Cy5 EGFP mRNA (5-moUTP): Assay Guide

  2026-08-17

  ARCA Cy5 EGFP mRNA (5-moUTP) combines direct Cy5 tracking with EGFP translation to distinguish RNA delivery from productive expression. This guide develops a decision-focused framework for mammalian-cell assays and translates pulmonary RNA-delivery findings into practical quality-control strategies.

• Chronic Hypoxia Primes Pain Through Peripheral Macrophages

  2026-08-16

  This study identifies peripheral macrophages as a causal contributor to nociceptor priming after chronic intermittent hypoxia, a mouse model of obstructive sleep apnea. By separating intermittent hypoxia from sleep fragmentation and testing both sexes, the work links recurrent hypoxemia to immune recruitment, inflammatory signaling, and persistent pain-related sensitization.

• Cyclosporin A for Reliable Cell Assays

  2026-08-15

  This scenario-driven guide explains how Cyclosporin A, SKU B1922, can support reproducible studies of cell viability, mitochondrial function, immunosuppression, and pyroptosis. It covers solvent compatibility, protocol design, interpretation of mitophagy experiments, and practical product-selection criteria.

• 2-NBDG: From Uptake Signal to Translational Insight

  2026-08-15

  2-NBDG is more than a fluorescent glucose analog: it is a decision tool for connecting transporter activity, intracellular trapping, insulin resistance, and disease-model biology. This article examines how 2-NBDG can strengthen glucose metabolism assays, interpret findings from a recent linarin study in insulin-resistant HepG2 cells, and support more disciplined translational strategy across flow cytometry, fluorescence microscopy, and microplate workflows.

• Triiodothyronine (T3) for Beige Adipocyte Assays

  2026-08-14

  Use Triiodothyronine (T3) as a controlled endocrine input in beige adipocyte differentiation, thermogenesis, and cellular metabolism assays. This workflow combines thyroid hormone receptor activation with SEMA3E, β-catenin, gene-expression, and mitochondrial respiration readouts to distinguish metabolic programming from nonspecific toxicity.

• Triiodothyronine in SEMA3E Thermogenesis Assays

  2026-08-14

  Triiodothyronine (T3) can add an endocrine dimension to SEMA3E–β-catenin studies of beige adipocyte thermogenesis. This article presents a causal assay framework that separates thyroid hormone receptor activation from adipocyte differentiation, mitochondrial respiration, and pathway-specific rescue.

• Omeprazole A2845: Research Protocol Guide

  2026-08-13

  Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled studies of gastric acid secretion, proton-pump inhibition, and antiulcer activity. It is intended for scientific research workflows only, not for diagnostic, medical, or clinical use, and its water and ethanol insolubility must be addressed during preparation.

• Trolox Workflows for Oxidative Stress Assays

  2026-08-13

  Trolox is a practical, cell-permeable antioxidant benchmark for hydrogen peroxide protection, lipid peroxidation studies, and high-throughput antioxidant screening. This guide shows how to formulate, dose, and interpret Trolox without confusing broad redox protection with ferroptosis-specific rescue.

• AMG 487 CXCR3 Antagonist Workflow Guide

  2026-08-12

  AMG 487 provides a receptor-focused way to dissect CXCR3 signaling across chemotaxis, calcium flux, and macrophage polarization assays. This practical guide combines potency-informed assay design with state-aware controls inspired by research on the CXCL10-CXCR3-LAMP1 axis.

447 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page